Last Updated : January 21, 2025
Details
| Call for patient/clinician input open | February 05, 2024 |
|---|---|
| Call for patient/clinician input closed | April 02, 2024 |
| Clarification: - Patient input submission received from The Leukemia and Lymphoma Society of Canada (LLSC) and Heal Canada | |
| Submission received | March 19, 2024 |
| Submission accepted | April 03, 2024 |
| Review initiated | April 04, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | June 21, 2024 |
| Deadline for sponsors comments | July 03, 2024 |
| CADTH review report(s) and responses to comments provided to sponsor | August 01, 2024 |
| Expert committee meeting (initial) | August 14, 2024 |
| Draft recommendation issued to sponsor | August 28, 2024 |
| Draft recommendation posted for stakeholder feedback | September 05, 2024 |
| End of feedback period | September 19, 2024 |
| Final recommendation issued to sponsor and drug plans | October 04, 2024 |
| Final recommendation posted | October 23, 2024 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | October 21, 2024 |
| CADTH review report(s) posted | January 21, 2025 |